Can probiotics reduce inflammation in people?
Probiotics show promise for reducing inflammation, but animal and lab findings do not prove they work in people.
A Frontiers editorial reviews evidence relevant to Probiotic Supplementation. It brings together lab tests, computer models, animal studies, and human studies. The main takeaway is promise, not proof. Results depend on the exact bacteria tested and the evidence behind them.
One study tested Lactobacillus rhamnosus GG, a specific type of helpful bacteria. It involved rats with lung injury caused by sepsis, a dangerous response to infection. The rats had better lung function and less inflammation after treatment. Their gut bacteria also returned toward a healthier balance. These findings do not establish the same benefits in people.
The editorial also describes changes in mouth bacteria and markers measured in saliva. Those effects varied by dose and strain—the specific version of a bacterium. For irritable bowel syndrome, which causes belly pain and changed bowel habits, it stresses testing each strain separately. A broad bacteria name alone does not tell the whole story.
The supplied excerpt gives no effect sizes, doses, or study lengths. It also flags limits in human studies, including study size and follow-up time. Differences in who was studied and what was measured matter, too.
For BioSocial members, this makes detailed tracking more useful than a simple yes-or-no verdict. A log could pair the exact strain and dose with daily symptom scores. Comparing notes with members using the same strain may offer better context. Those patterns can describe personal experience without proving that a product caused a change.
What changes, if any, have you tracked with a specific probiotic strain?


Comments
No comments yet.